ClearanceBrief
Recall Z-0755-2020 ยท CCK Analyzer, Gas, Carbon-Dioxide, Gaseous-Phase

GE Healthcare, LLC

CARESCAPE Respiratory Module E-sCOVX

DateJan 10, 2020 (initiated Sep 27, 2019)
StatusTerminated
ReasonDisplayed End Tidal Oxygen (EtO2) and Fraction of Inspired Oxygen (FiO2) values may be incorrect which could cause up to 50% measurement error in the EtO2/FiO2 values.
Root causeProcess control
ActionThe firm issued the Urgent Medical Device Correction Letter dated 09/27/2019. The letter describes the failure and requests replacement of the affected module with another module. If a replacement is not available, the consignee is directed to follow the instructions below to ensure that your respiratory module O2 reading is within specifications (a) before any new patient case is started and (b) for prolonged patient cases, at a minimum of once a day: 1) Connect the module to the host device; 2) Ensure the module is fully warmed up by having it powered on for minimum 20 minutes; 3) Configu
Quantity3 units
DistributionUS OUS: Australia, Austria, Belgium, Bolivia, Brazil, Canada, Chile, China, Colombia, Costa Rica, Czech Republic, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Italy, Japan, Korea (Republic of), Malaysia, Mexico, Myanmar, Netherlands, New Zealand, Peru, Poland, Republic of Serbia,
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K150245CARESCAPE Respiratory Modules, E-sCO, E-sCOV, E-sCOVX, E-sCAiO, E-sCAiOV, E-sCAiOVX
GE Healthcare Finland Oy, Jul 17, 2015
K171028CARESCAPE Respiratory MOdules, E-sCO, E-sCOV, E-sCOVX, E-sCAiO, E-sCAiOV, E-sCAiOVX and accessories
GE Healthcare Finland Oy, Aug 17, 2017
K183394CARESCAPE Respiratory Modules, E-sCO, E-sCOV, E-sCOVX, E-sCAiO
GE Healthcare Finland Oy, May 1, 2019